I think Fulgent Genetics
is extremely cheap and institutional investors are just barely starting to take notice. The near term catalysts for massive upside are already in play and not priced into the stock.
All ideas are based on my own research. As always I recommend you take the time to do diligence on your investments to make sure they match your risk and objectives.